Pharma-Bio Serv, Inc. (PBSV) Stock Price & Analysis
Pharma-Bio Serv, Inc. (PBSV) fell 27.59% to USD 0.42 as of July 25, 2026 at 05:32 UTC, according to Nexqual real-time market data.
PBSV last closed at USD 0.58; the session ranged USD 0.58–0.58 on volume of 1,000 shares. Market capitalization is $9.62M, with a 52-week range of USD 0.42–1.36 (OQB). Source: Nexqual, July 25, 2026 at 05:32 UTC.
Key Statistics (as of July 25, 2026 at 05:32 UTC)
| Price | USD 0.42 |
|---|---|
| Change | ▼ 27.59% (down) |
| Previous Close | USD 0.58 |
| Open | USD 0.58 |
| Day Range | USD 0.58 – 0.58 |
| 52-Week Range | USD 0.42 – 1.36 |
| Volume | 1,000 shares |
| Market Cap | $9.62M |
| Exchange | OQB |
Technical Analysis (PBSV)
Nexqual's technical model rates PBSV "SELL" based on 3 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 05:32 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 29.76 (oversold) |
| vs SMA50 | Below (USD 0.55) |
| MACD | -0.01 (negative) |
Analyst Ratings (PBSV)
Wall Street analysts rate PBSV "None" based on 1 analysts, with a mean price target of USD 1.55 (range USD 1.55–1.55), per Nexqual as of July 25, 2026 at 05:32 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 1.55 |
| High Target | USD 1.55 |
| Low Target | USD 1.55 |
| Buy / Hold / Sell | 0 / 0 / 0 |
Earnings (PBSV)
| EPS Estimate | USD 0.03 |
|---|---|
| Revenue Estimate | $2.70M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-04-30 | USD 0.01 vs est 0.03 ▼ miss |
| 2026-01-31 | USD 0 vs est 0.02 ▼ miss |
| 2025-10-31 | USD 0 vs est 0.03 ▼ miss |
| 2025-07-31 | USD -0.01 vs est 0.03 ▼ miss |
Source: Nexqual, July 25, 2026 at 05:32 UTC.
Financials & Fundamentals (PBSV)
| Total Revenue | $9.11M |
|---|---|
| Revenue Growth (YoY) | +11.80% |
| Gross Margin | +32.35% |
| Operating Margin | +5.35% |
| Profit Margin | +0.68% |
| ROE | +0.55% |
| Current Ratio | 10.8 |
| Total Cash | $8.47M |
| Total Debt | $0 |
| Free Cash Flow | $-473,199 |
Source: Nexqual, July 25, 2026 at 05:32 UTC.
Financial Health Score (PBSV)
Nexqual rates Pharma-Bio Serv, Inc.'s overall financial health "Weak" across five dimensions, as of July 25, 2026 at 05:32 UTC.
| Growth | Weak — Revenue -5% YoY (annual), declining |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Mixed — $8M cash, no debt |
| Cash Flow | Weak — FCF negative: -$473K, burning cash |
| Efficiency | Weak — ROE 1%, ROA -2.0% |
Ownership (PBSV)
| Insider Ownership | +64.94% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 22.90M |
| Float | 8.41M |
Source: Nexqual, July 25, 2026 at 05:32 UTC.
Leadership (PBSV)
Pharma-Bio Serv, Inc. is led by Victor Sanchez (age 54), CEO, President & President of European Operations, per Nexqual as of July 25, 2026 at 05:32 UTC.
| CEO, President & President of European Operations | Victor Sanchez (age 54) |
|---|---|
| CFO, VP of Finance & Administration and Secretary | Pedro J. Lasanta (age 65) |
From Pharma-Bio Serv, Inc.'s Latest SEC 10-K Filing (filed 2026-01-29)
Key Strengths & Strategy (as disclosed to the SEC)
- Pharma-Bio Serv, Inc. operates as a regulatory affair, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally.
- The company offers a broad range of technical compliance consulting services, including regulatory affairs, quality assurance, compliance, technology transfer, validation, engineering, project management, and process support.
- It serves pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PFHO | Pacific Health Care Organizatio | USD 0.83 | ▲ 0% |
| GLGI | Greystone Logistics, Inc. | USD 0.25 | ▲ 0% |
| NROM | Noble Roman's, Inc. | USD 0.67 | ▲ 8.06% |
| IEHC | IEH Corp. | USD 23.19 | ▼ 1.32% |
| SCND | Scientific Industries, Inc. | USD 0.58 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 05:32 UTC. This page is informational and not investment advice.